Bronchoscopy during COVID-19 pandemic, ventilatory strategies and procedure measures.


Journal

Panminerva medica
ISSN: 1827-1898
Titre abrégé: Panminerva Med
Pays: Italy
ID NLM: 0421110

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 5 10 2021
medline: 30 12 2021
entrez: 4 10 2021
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has changed bronchoscopy practices worldwide. Bronchoscopy is a high-risk aerosol-generating procedure with a potential for direct SARS-CoV-2 exposure and hospital-acquired infection. Current guidelines about personal protective equipment and environment considerations represent key competencies to minimize droplets dispersion and reduce the risk of transmission. Different measures should be put in field based on setting, patient's clinical characteristics, urgency and indications of bronchoscopy. The use of this technique in SARS-CoV-2 patients is reported primarily for removal of airway plugs and for obtaining microbiological culture samples. In mechanically ventilated patients with SARS-CoV-2, bronchoscopy is commonly used to manage complications such as hemoptysis, atelectasis or lung collapse when prone positioning, physiotherapy or recruitment maneuvers have failed. Further indications are represented by assistance during percutaneous tracheostomy. Continuous positive airway pressure, non-invasive ventilation support and high flow nasal cannula oxygen are frequently used in patient affected by Coronavirus disease 2019 (COVID-19): management of patients' airways and ventilation strategies differs from bronchoscopy indications, patient's clinical status and in course or required ventilatory support. Sedation is usually administered by the pulmonologist (performing the bronchoscopy) or by the anesthetist depending on the complexity of the procedure and the level of sedation required. Lastly, elective bronchoscopy for diagnostic indications during COVID-19 pandemic should be carried on respecting rigid standards which allow to minimize potential viral transmission, independently from patient's COVID-19 status. This narrative review aims to evaluate the indications, procedural measures and ventilatory strategies of bronchoscopy performed in different settings during COVID-19 pandemic.

Identifiants

pubmed: 34606187
pii: S0031-0808.21.04533-X
doi: 10.23736/S0031-0808.21.04533-X
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-538

Auteurs

Filippo Patrucco (F)

Respiratory Diseases Unit, Medical Department, AOU Maggiore della Carità, Novara, Italy - filippo.patrucco@maggioreosp.novara.it.
Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy - filippo.patrucco@maggioreosp.novara.it.

Giuseppe Failla (G)

Interventional Pneumology Unit, Department of Onco-Hematology and Pneumo-Hematology, AORN A. Cardarelli, Naples, Italy.
Diagnostic and Therapeutic Bronchoscopy Unit, ARNAS Civico e Benfratelli, Palermo, Italy.

Giovanni Ferrari (G)

Pulmonology and Semi-Intensive Respiratory Units, Medical Department, Mauriziano Hospital, Turin, Italy.

Thomas Galasso (T)

Interventional Pneumology Unit, Thoraco-Cardio-Vascular Department, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.

Piero Candoli (P)

Interventional Pneumology Unit, Thoraco-Cardio-Vascular Department, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.

Michele Mondoni (M)

Pulmonology Unit, Department of Cardio-Respiratory Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Milan, Italy.

Roberto Piro (R)

Pulmonology Unit, Azienda Unità Sanitaria Locale - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Nicola C Facciolongo (NC)

Pulmonology Unit, Azienda Unità Sanitaria Locale - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Teresa Renda (T)

Pneumology and Thoraco-Pulmonary Physiopathology Unit, Department of Cardio-Thoraco-Vascular Medicine, Careggi Hospital, Florence, Italy.

Mario Salio (M)

Respiratory Diseases Unit, Department of Internal Medicine, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy.

Raffaele Scala (R)

Pneumology Unit, Department of Cardio-Thoraco-Neuro-Vascular Medicine, San Donato Hospital, Azienda USL Toscana Sud Est, Arezzo, Italy.

Paolo Solidoro (P)

Pneumology Unit, Department of Cardiovascular and Thoracic Medicine, AOU Città della Salute e della Scienza, Turin, Italy.
Department of Medical Sciences, University of Turin, Turin, Italy.

Alessio Mattei (A)

Pneumology Unit, Department of Cardiovascular and Thoracic Medicine, AOU Città della Salute e della Scienza, Turin, Italy.

Paolo Donato (P)

Intensive Care Unit 1, Emergency Department, AOU Maggiore della Carità, Novara, Italy.

Rosanna Vaschetto (R)

Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
Intensive Care Unit 1, Emergency Department, AOU Maggiore della Carità, Novara, Italy.

Piero E Balbo (PE)

Respiratory Diseases Unit, Medical Department, AOU Maggiore della Carità, Novara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH